Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.91% |
| 2 | Technology | 7.43% |
| 3 | Financials | 6.52% |
| 4 | Consumer Discretionary | 5.69% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
CALL
WIX.com
WIX
$3.6B
| $242K | ﹤0.01% |
+2,400
| New | +$313K |
|
|
CBIO
3252
Crescent Biopharma
CBIO
$631M
| $241K | ﹤0.01% |
1,058
+276
| +35% | +$105K |
|
3253
Tilray
TLRY
$671M
| $241K | ﹤0.01% |
3,509
-561
| -14% | -$78.3K |
|
|
NPKI
3254
NPK International
NPKI
$1.12B
| $241K | ﹤0.01% |
269,133
-60,303
| -18% | -$226K |
|
3255
PUT
Allstate
ALL
$65.1B
| $238K | ﹤0.01% |
+2,600
| New | +$283K |
|
3256
Vanguard Long-Term Bond ETF
BLV
$5.78B
| $237K | ﹤0.01% |
2,221
-3,219
| -59% | -$336K |
|
3257
Larimar Therapeutics
LRMR
$432M
| $237K | ﹤0.01% |
25,658
-4,964
| -16% | -$65.3K |
|
3258
PUT
uniQure
QURE
$3.54B
| $237K | ﹤0.01% |
5,000
| – | – |
|
3259
NRC Health Common Stock
NRC
$487M
| $236K | ﹤0.01% |
5,189
-38
| -0.7% | -$2.28K |
|
3260
iShares Russell 2000 ETF
IWM
$81.7B
| $235K | ﹤0.01% |
2,056
-704,553
| -100% | -$105M |
|
3261
National Grid
NGG
$81.6B
| $235K | ﹤0.01% |
4,567
-106,506
| -96% | -$5.88M |
|
3262
Northrim BanCorp
NRIM
$568M
| $235K | ﹤0.01% |
34,844
-65,712
| -65% | -$566K |
|
|
BRQS
3263
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
| $235K | ﹤0.01% |
1,103
-1
| -0.1% | -$287 |
|
|
SOLN
3264
DELISTED
The Southern Company
SOLN
| $233K | ﹤0.01% |
5,249
-9,295
| -64% | -$487K |
|
3265
Black Diamond Therapeutics
BDTX
$129M
| $232K | ﹤0.01% |
+9,296
| New | +$283K |
|
3266
CALL
GDS Holdings
GDS
$6.61B
| $232K | ﹤0.01% |
4,000
-1,600
| -29% | -$89.2K |
|
3267
REX American Resources
REX
$1.37B
| $232K | ﹤0.01% |
29,946
-11,016
| -27% | -$125K |
|
3268
CALL
RH
RH
$2.67B
| $231K | ﹤0.01% |
+2,300
| New | +$429K |
|
|
PENG
3269
Penguin Solutions Inc
PENG
$2.58B
| $231K | ﹤0.01% |
18,992
-426,550
| -96% | -$6.24M |
|
|
RBNC
3270
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $231K | ﹤0.01% |
+20,465
| New | +$393K |
|
3271
CALL
Energy Transfer Partners
ET
$72.4B
| $230K | ﹤0.01% |
50,000
-160,000
| -76% | -$1.7M |
|
|
SAVE
3272
DELISTED
Spirit Airlines, Inc.
SAVE
| $230K | ﹤0.01% |
17,882
-982,042
| -98% | -$31.6M |
|
3273
Anterix
ATEX
$1.81B
| $229K | ﹤0.01% |
+5,013
| New | +$227K |
|
3274
CALL
AB InBev
BUD
$155B
| $229K | ﹤0.01% |
+5,200
| New | +$339K |
|
3275
Danaos Corp
DAC
$2.78B
| $229K | ﹤0.01% |
57,373
-73,417
| -56% | -$449K |
|
Similar funds
Israel Englander's Q1 2020 Portfolio in Review
As of Q1 2020, Israel Englander held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Danaher worth $133M.
- Israel Englander's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Israel Englander added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Israel Englander's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Israel Englander fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Israel Englander opened 789 new positions and closed 1,154 in Q1 2020.
- Israel Englander's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.